维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Essapen"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Epidermal growth factor receptor inhibitors in cancer treatment:advances,challenges and opportunities显示文摘	MODJTAHEDI H ESSAPEN S	2009	Anticancer Drugs2009，20，10：	1
2	Epidermal growth factor receptor inhibitors in cancer treatment: advances challenges and op- portunities 显示文摘	Modjtahedi H Essapen S	2009	Anticancer Drugs2009，20，10：	1
3	The expres- sion and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological pa- rameters显示文摘	Essapen S Thomas H Green M	2004	IntJ Oncol2004，24，：	1
4	Accuracy of set-up of thoracic radiotherapy:prospective analysis of 24 patients treated with radiotherapy for lung cancer显示文摘	Knowles C Norman A	2002	Br J Radiol2002，75，890：	1
5	Epidermal growth factor receptor inhibitors in cancer treatment:advances challenges and opportunities显示文摘	Modjtahedi H Essapen S	2009	Anticancer Drugs2009，20，10：	1
6	Sister Mary Joseph's Nodule as a First Manifestation of Primary Peritoneal Cancer 显示文摘	Iavazzo C Madhuri K Essapen S	2012	Case Rep Obstet Gynecol2012，2012，46：	1
7	Epidermal growth factor receptor inhibitors in cancer treatment:advances,challenges and opportunities显示文摘	Modjtahedi H Essapen S	2009	Anticancer Drugs2009，20，10：	1
8	Epidermal growth factor receptor in hibitors cancer treatment advances challenges and opptunities 显示文摘	Modjtahedi H Essapen S	2009	Anticancer Drugs2009，20，10：	1
9	Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities 显示文摘	Madjtahedi H Essapen S	2009	Antieaneer Drugs2009，20，10：	1
10	Therapeutic application of mono- clonal antibodies in cancer: advances and ehallenges显示文摘	H Modjtahedi S Ali S Essapen	2012	Br Med Bull2012，104，：	1
11	Epidermal growth factor receptorinhibitors in cancer treatment: advances, challenges and opportu- nities显示文摘	MODJTAHEDI H ESSAPEN S	2009	Anticancer Drugs2009，20，10：	1
12	Prognostic significance and targeting of HER family in colorectal cancer 显示文摘	Khelwatty SA Essapen S Seddon AM	2013	Front Biosci2013，18，：	1
13	Therapeutic application of monoelonal antibodies in cancer:advances and challenges显示文摘	MODJTAHEDI H ALl S ESSAPEN S	2012	Br Med Bull2012，104，10：	1
14	Coexpression of the IGF -IR,EGFR and HER -2 is common in colorectal cancer pa- tients显示文摘	Cunningham MP Essapen S Thomas H	2006	Int J Oncol2006，28，：	1
15	Epidermal growth factor recep- tor inhibitors in cancer treatment :advances,challenges and opportunities显示文摘	Modjtahedi H Essapen S	2009	Anticancer Drugs2009，20，10：	1
16	Epidermal growth factor receptor inhibitors in cancer treatment:advances,challenges and opportunities显示文摘	MODJTAHEDI H ESSAPEN S	2009	Anticancer Drugs2009，20，10：	1
17	The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters 显示文摘	Essapen S Thomas H Green M	2004	Int J Onco12004，24，2：	1
18	The expression and prognostic significance of HER-2 in colorectal cancer and its relationship with clinicopathological parameters显示文摘	Essapen S Thomas H Green M	2004	Int J Oncol2004，24，2：	1
19	Epidermal growth factor receptor inhibitors in cancer treatment:advances,challenges and opportunities显示文摘	Modjtahedi H Essapen S		0，，10：	1
20	Epidermal growth factor receptor inhibi-tors in cancer treatment:advances,chal enges and opportunities显示文摘	Modjtahedi H Essapen S		0，，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示